In response to the novel coronavirus (SARS-CoV-2) outbreak, 4M Healthcare has worked rapidly to develop a new multiplex real-time RT-PCR diagnostic test to enable clinical and government providers to quickly diagnose COVID-19 caused by SARS-CoV-2 infection.

• 4M Healthcare is utilizing Applied Biosystems TaqPath COVID-19 Combo Assay. This is a fast, highly sensitive multiplex diagnostic solution that is needed for the real-time PCR detection of RNA from the SARS-CoV-2 virus.
• 24 to 36 hour turn-around time
• Nasopharyngeal and Oropharyngeal swabs for collection methods
• During the COVID-19 emergency period declared by the Public Health Act, providers are required to make public the cash prices for the diagnostic test for COVID-19 [Reference: CARES Act Sec. 3202].  The cash price shown is for 4M Healthcare in all care settings where tests are performed. *COVID-19 Diagnostic Test Cash Price: $100.00